Yahoo Finance

Estimated Discount To Fair Value: 35.3%

Takara Bio is trading at ¥1,065, well below its estimated fair value of ¥1,647.29, highlighting its potential undervaluation based on cash flows. Forecasts indicate earnings growth of 30.2% annually over the next three years, surpassing the Japanese market's 8.7%. However, profit margins have decreased significantly from last year’s 17% to 0.3%, and return on equity is expected to remain low at 4.4%. Recent guidance projects modest sales and profit increases for FY2025.

• In light of our recent growth report, it seems possible that Takara Bio's financial performance will exceed current levels.

• Get an in-depth perspective on Takara Bio's balance sheet by reading our health report here.

Strike CompanyLimited

Overview: Strike Company, Limited offers mergers and acquisitions brokerage services for small and medium-sized companies in Japan, with a market cap of ¥86.12 billion.

Operations: The company generates revenue from its M&A Intermediary Business, amounting to ¥17.97 billion.

Estimated Discount To Fair Value: 32.7%

Strike Company Limited, trading at ¥4,485, is significantly below its fair value estimate of ¥6,662.58. Its earnings are forecast to grow 18.1% annually, outpacing the Japanese market's 8.7%. Despite this growth and a substantial dividend increase to ¥85 per share for FY2024/9, the company faces challenges with a volatile share price and an unstable dividend history. Recent executive appointments aim to strengthen corporate strategy and advisory functions.

• Our earnings growth report unveils the potential for significant increases in Strike CompanyLimited's future results.

• Click to explore a detailed breakdown of our findings in Strike CompanyLimited's balance sheet health report.

Next Steps

• Investigate our full lineup of 83 Undervalued Japanese Stocks Based On Cash Flows right here.

• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include TSE:4443 TSE:4974 and TSE:6196.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com